Xtl Biopharmaceuticals (XTLB) Change in Inventory (2013 - 2014)

Xtl Biopharmaceuticals (XTLB) posted quarterly Change in Inventory of $104000.0 for Q4 2014, down 2.8% year-on-year from $107000.0 in Q4 2013, and up 31.65% on a QoQ basis from $79000.0 in Q3 2014.

Xtl Biopharmaceuticals (XTLB) Change in Inventory (2013 - 2014) Analysis & Trends

Xtl Biopharmaceuticals (XTLB) has reported Change in Inventory for 2 consecutive years, with $104000.0 the latest figure, recorded in Q4 2014.

  • Quarterly Change in Inventory fell 2.8% year-over-year to $104000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $184000.0 (up 352.05% YoY) and the FY2014 annual result came in at $184000.0, up 352.05% from the prior year.
  • Change in Inventory climbed to $104000.0 in Q4 2014 per XTLB's latest filing, from $79000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for XTLB reached as high as $107000.0 in Q4 2013 and fell as low as -$144000.0 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - -
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn - -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn - -
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn 71.84 Mn
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 63.57 Bn 63.57 Bn - -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn 3.32 Mn
10 Xtl Biopharmaceuticals 2.51 Bn 2.51 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2014 104,000.00
Dec 31, 2014 104,000.00
Sep 30, 2014 79,000.00
Sep 30, 2014 79,000.00
Jun 30, 2014 -93,000.00
Jun 30, 2014 -93,000.00
Mar 31, 2014 94,000.00
Mar 31, 2014 94,000.00
Dec 31, 2013 107,000.00
Dec 31, 2013 107,000.00
Sep 30, 2013 -144,000.00
Sep 30, 2013 -144,000.00
Jun 30, 2013 58,000.00
Jun 30, 2013 58,000.00
Mar 31, 2013 -94,000.00
Mar 31, 2013 -94,000.00